Relating to breast implants, the Food and Drug Administration, and breast care.
This bill died when its Congress ended.
Bills don't carry over between Congresses. Without re-introduction in a new session, it cannot advance.
Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.
Filed in the House
This house resolution has been filed and is awaiting consideration. It only needs to pass the House to take effect.
Who introduced this
Ask AI About This Bill
Get plain-language answers with direct quotes from the bill text.
Your Representatives
Enter your address to see how your representatives voted on this bill.
Your address is only used to find your district and is never saved. See how it works
Votes
Public Opinion
No votes yet — be the first to weigh in.
to cast your vote
Your voice matters — let representatives know where you stand.
Comments
No comments yet. to be the first to weigh in.